Jonah Comstock

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.

Stay updated on the latest STEM Healthcare news from Reuters Pharma USA 2024, featuring insights from global account lead at STEM, Serena Goodwin on the impact of AI in healthcare.

Merino Perugini from Nestlé Health Science sat down for an exclusive interview with Jonah Comstock from Reuters Pharma USA to discuss the company’s latest innovations and successes in the healthcare industry. Get insights into their strategies and future plans.

The ADHD drug shortage continues - what’s causing the ongoing lack of access to medications like Adderall and Methylphenidate? This blog post explores the factors behind the shortage.

Explore innovation, investment, and policies at the US Pharma and Biotech Summit 2024. Join industry leaders, regulators, and investors to discuss trends shaping healthcare.

In this special edition of the pharmaphorum podcast, the tables have turned as Jonah Comstock puts editors Eloise McLennan and Nicole Raleigh in the hot seat to discuss the biggest trends and talking points from last month’s Reuters Pharma Europe 2024 in Barcelona.

What are the pros and cons of synthetic clinical trials? Get insights from podcast guests Web Sun and Tracy Mayne on the latest developments in this cutting-edge field.

In this podcast interview with Dr Fred Aslan from Artiva Biosciences, explore the potential of NK cells in cell therapy and how they could revolutionise the field of immunotherapy beyond CAR-T therapies.

Explore the latest hires in pharma and biotech, including executive moves at Seaport Therapeutics, Anthos Therapeutics, Pfizer, and Novartis, from April 2024. Stay updated with the industry’s top talent movements.

Sanofi's Dupixent scores double COPD win in US, China